Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy

被引：10

作者：

Garabedian, M. J. ^{[1
]}

Hansen, W. F. ^{[1
]}

Gianferrari, E. A. ^{[1
]}

Lain, K. Y. ^{[1
]}

Fragneto, R. Y. ^{[2
]}

Campbell, C. L. ^{[3
]}

Booth, D. C. ^{[3
]}

机构：

[1] Univ Kentucky, Dept Obstet & Gynecol, Lexington, KY 40536 USA

[2] Univ Kentucky, Dept Anesthesiol, Lexington, KY 40536 USA

[3] Univ Kentucky, Dept Cardiol, Lexington, KY 40536 USA

来源：

JOURNAL OF PERINATOLOGY | 2010年 / 30卷 / 09期

关键词：

idiopathic pulmonary arterial hypertension; epoprostenol; pregnancy; MANAGEMENT; THERAPY;

D O I：

10.1038/jp.2010.15

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Idiopathic pulmonary arterial hypertension is a rare condition associated with significant maternal mortality. We report the management of a 37-year-old multigravida with severe disease using epoprostenol, a multidisciplinary approach, and a planned delivery. Although the patient survived the pregnancy, her pulmonary function significantly worsened. Epoprostenol, a pulmonary vasodilator, should be considered when indicated during pregnancy. Neither fetal nor neonatal harm was identified. Journal of Perinatology (2010) 30, 628-631; doi:10.1038/jp.2010.15

引用

页码：628 / 631

页数：4

共 50 条

[1] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
M J Garabedian
W F Hansen
E A Gianferrari
K Y Lain
R Y Fragneto
C L Campbell
D C Booth
Journal of Perinatology, 2010, 30 : 628 - 631
[2] Epoprostenol for the treatment of pulmonary arterial hypertension
Cristo Ropero, Maria Jose
Cruz-Utrilla, Alejandro
Pilar Escribano-Subias, Maria
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (08) : 1005 - 1013
[3] Epoprostenol sodium for treatment of pulmonary arterial hypertension
Saito, Yukihiro
Nakamura, Kazufumi
Akagi, Satoshi
Sarashina, Toshihiro
Ejiri, Kentaro
Miura, Aya
Ogawa, Aiko
Matsubara, Hiromi
Ito, Hiroshi
VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 265 - 270
[4] Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
Mohammadi, Asma
Matos, Wanessa F.
Intriago, Cesar
Thakkar, Keval
Jahan, Nasrin
Shah, Heeya
Nishu, Rifath I.
Marzban, Sima
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
[5] Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment
Hall, S. M.
Davie, N.
Klein, N.
Haworth, S. G.
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 851 - 860
[6] Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
Timofeev, Julia
Ruiz, George
Fries, Melissa
Driggers, Rita W.
AJP REPORTS, 2013, 3 (02): : 71 - 74
[7] Epoprostenol in pulmonary arterial hypertension
Jacobs, Wouter
Vonk-Noordegraaf, Anton
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (01) : 83 - 90
[8] A new epoprostenol formulation for the treatment of pulmonary arterial hypertension
Fuentes, Amaris
Coralic, Aida
Dawson, Kyle L.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (16) : 1389 - 1393
[9] Epoprostenol Rescue Therapy In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension
Roos, Adrienne M.
Pasarikovski, Christopher
Kron, Amie T.
Granton, John T.
Lee, Peter
Thenganatt, John
Johnson, Sindhu R.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S1099 - S1099
[10] EPOPROSTENOL RESCUE THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION AND IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
Roos, A. M.
Pasarikovski, C. R.
Kron, A.
Granton, J. T.
Lee, P.
Thenganatt, J.
Johnson, S. R.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S86 - S87

← 1 2 3 4 5 →